United States· US:0591-0395_676211b0-1b6c-426b-ad1a-57bb726fd61c
Pentazocine and naloxone
A pentazocine and naloxone product containing pentazocine hydrochloride; naloxone hydrochloride, registered in United States by Actavis Pharma, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PENTAZOCINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
- Manufacturer
- Actavis Pharma, Inc.
- Country
- United States (US)
- ATC code
- N02AD51
- ATC class
- Pentazocine and naloxone
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc110591-0395-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N02AD51
Pentazocine and naloxone, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/32879b72-c63c-47c4-b5e6-a09d78f59870 GET /v1/drugs/32879b72-c63c-47c4-b5e6-a09d78f59870?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50; .5",
"substance": "PENTAZOCINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE",
"productndc": "0591-0395",
"dosage_form": "TABLET",
"dea_schedule": "CIV",
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA074736",
"marketing_category": "ANDA"
}See everything about pentazocine and naloxone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.